PCR Tricuspid Focus Group - referral meeting in Antwerp

Tricuspid Focus Group

A referral meeting is a locally organised seminar, addressed to referring physicians with the objective of disseminating messages relevant to the referral and treatment of patients with tricuspid valve disease. It is an independent, post-graduate educational event initiated by a PCR Tricuspid Focus Group member.

Practical information

  • 16 January 2026
  • The registration to the meeting is free of charge
  • This meeting will be in Dutch
  • Zoo Antwerpen, Koningin Astridplein 20, 2018 Antwerpen, België
  • Target audience: Cardiologists, physician assistants, nurses, echocardiography technicians, cath lab staff, and all healthcare professionals with an  interest in tricuspid regurgitation.

Organising Committee

Martin Swaans

Imaging / Echography physician

St. Antonius Ziekenhuis Nieuwegein - Nieuwegein, Netherlands

Dr. Vrijkorte

Clinical researcher

St. Antonius Ziekenhuis Nieuwegein - Nieuwegein, Netherlands

Learning Objectives:

Join us if you want to

  • Understand the pathophysiology and Clinical Impact of TR – mechanisms, clinical significance, and progression, including heart failure
  • Apply Advanced Multimodal Imaging in TR Evaluation – TTE (2D/3D), CT, CMR
  • Learn about the Treatment Options and Patient Selection – surgical vs transcatheter, multidisciplinary approach

Get in touch directly with the organisers to learn more about this referral meeting.

CONTACT BY EMAIL

We are grateful for the support of the below Industrial Partner who are joining forces with the PCR Tricuspid Focus Group Partners to make this Referral meeting possible.

Abbott
Edwards
GE Healthcare
Medtronic
P&F Products Features
philips
Siemens

Introducing the PCR Tricuspid Focus Group

Discover an overview of the new initiative’s mission and five ongoing working groups dedicated to improving the treatment of patients with tricuspid valve disease. Interested in following the Tricuspid Focus Group from near or afar? Use the hashtag #PCRtricuspid on Twitter or Facebook and make sure you don't miss anything!

Learn more